Feds To Invest Up To $100 Million In Leading-Edge, Evidence-Based Approaches To Behavioral Health Treatment

The federal Advanced Research Projects Agency for Health (ARPA-H) plans to invest up to $100 million in leading-edge quantitative measures of mental and behavioral health through its new Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health (EVIDENT) initiative. ARPA-H supports development of solutions for challenging social problems related to health.

Through a solicitation, ARPA-H will seek multimodal, longitudinal data collected in registered clinical trials testing the effects of rapid-acting behavioral health interventions. Such interventions could include medications, neuromodulation, or digital therapeutics. The data collected could include psychological, social, digital, and biological samples . . .